These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 3874779)
1. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SKF 38393. Scatton B; Dubois A Eur J Pharmacol; 1985 Apr; 111(1):145-6. PubMed ID: 3874779 [No Abstract] [Full Text] [Related]
2. Autoradiographic distribution of binding sites of [3H]SKF 38393, a selective dopamine D1 receptor agonist, in the mouse forebrain. Juhász M; Kobor G; Lajtha A; Vadász C Brain Res; 1987 Oct; 423(1-2):305-8. PubMed ID: 3499958 [TBL] [Abstract][Full Text] [Related]
3. Binding of [3H]SKF 38393 to dopamine D-1 receptors in rat striatum in vitro; estimation of receptor molecular size by radiation inactivation. Gredal O; Nielsen M J Neurochem; 1987 Feb; 48(2):370-5. PubMed ID: 3491877 [TBL] [Abstract][Full Text] [Related]
4. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors. Subramaniam S; Lucki I; McGonigle P Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781 [TBL] [Abstract][Full Text] [Related]
5. Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390. Gredal O; Nielsen M; Hyttel J Pharmacol Toxicol; 1987 Apr; 60(4):255-7. PubMed ID: 2954035 [TBL] [Abstract][Full Text] [Related]
7. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
8. Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats. Bhargava HN; Gulati A J Pharmacol Exp Ther; 1990 Mar; 252(3):901-7. PubMed ID: 2138669 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of D-1 dopamine receptors labelled by [3H]fluphenazine in homogenates of rat neostriatum. Cincotta M; de Vries DJ; Beart PM Neurosci Lett; 1985 Oct; 61(1-2):85-9. PubMed ID: 2867505 [TBL] [Abstract][Full Text] [Related]
10. Regulation of dopamine D1 receptors by chronic administration of structurally different D1 receptor antagonists: a quantitative autoradiographic study. Lappalainen J; Hietala J; Pohjalainen T; Syvälahti E Eur J Pharmacol; 1992 Jan; 210(2):195-200. PubMed ID: 1534766 [TBL] [Abstract][Full Text] [Related]
11. Evidence that dopamine receptors identified by [3H]dopamine in the ventricles of guinea-pig heart are of DA2 type. Sandrini M; Benelli A; Baraldi M Pharmacol Res Commun; 1986 Dec; 18(12):1151-7. PubMed ID: 3494256 [TBL] [Abstract][Full Text] [Related]
12. Occurrence of the D-1 dopamine receptor in the substantia nigra of several mammalian species: identification in binding studies using [125I]SCH 23982. Yamamoto T; Kebabian JW Brain Res; 1987 Mar; 407(2):398-400. PubMed ID: 3032368 [TBL] [Abstract][Full Text] [Related]
13. Reduction of [3H]nicotine binding in hypothalamic and cortical membranes by dopamine D1 receptors. Fuxe K; von Euler G; Finnman UB; Agnati LF Acta Physiol Scand; 1989 Jun; 136(2):295-6. PubMed ID: 2528887 [No Abstract] [Full Text] [Related]
14. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390. O'Boyle KM; Waddington JL Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559 [TBL] [Abstract][Full Text] [Related]
16. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434. Abrahams BS; Rutherford JD; Mallet PE; Beninger RJ Eur J Pharmacol; 1998 Feb; 343(2-3):111-8. PubMed ID: 9570457 [TBL] [Abstract][Full Text] [Related]
17. Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors. Czyrak A; Maćkowiak M; Fijał K; Chocyk A; Wedzony K Pol J Pharmacol; 1997; 49(5):305-16. PubMed ID: 9566029 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity. Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257 [TBL] [Abstract][Full Text] [Related]
19. New substituted 1-phenyl-3-benzazepine analogues of SK&F 38393 and N-methyl-thienopyridine analogues of dihydroxynomifensine with selective affinity for the D-1 dopamine receptor in human post-mortem brain. O'Boyle KM; Waddington JL Neuropharmacology; 1987 Dec; 26(12):1807-10. PubMed ID: 3501846 [TBL] [Abstract][Full Text] [Related]
20. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum. Thomas KL; Rose S; Jenner P; Marsden CD Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]